cefepime and Multiple-Organ-Failure

cefepime has been researched along with Multiple-Organ-Failure* in 2 studies

Other Studies

2 other study(ies) available for cefepime and Multiple-Organ-Failure

ArticleYear
Cefepime and diclofenac sodium combined treatment-potentiated multiple organ injury: Role of oxidative damage and disrupted lipid metabolism.
    Journal of biochemical and molecular toxicology, 2021, Volume: 35, Issue:12

    Concurrent exposure to antimicrobial and nonsteroidal anti-inflammatory drugs (NSAIDs) is usually inevitable in most infections and postsurgery. Consequently, the present study was designed to assess the intertwining impact of coadministration of cefepime (CP, a wide spectrum antibiotic) and diclofenac sodium (DF, an NSAID) on rat's liver, kidney, and testes. Rats received saline, CP (180 mg/kg/day, IM), DF (10 mg/kg/day, IM), or a combination of CP and DF. After 14 days, CP or DF induced tissue damage expressed by marked biochemical alterations in hepatic and renal function tests. Besides this, disrupted lipid metabolism and testosterone levels along with significant histological changes in hepatic, renal, and testicular tissues were noticed. A significant increase in malondialdehyde and decreases in superoxide dismutase and catalase activities alongside significant upregulated caspase 3 expression in tissues following CP or DF treatment suggested a bearable influence of oxidative stress, lipid peroxidation, and cell death. Accordingly, the simultaneous therapy of CP and DF evoked more obvious tissue damage than their individual treatment. Overall, data concluded that concurrent use of CP and DF in medical practice is a worrisome matter, so it should be done cautiously to avoid synergistic deleterious outcomes.

    Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Cefepime; Diclofenac; Lipid Metabolism; Male; Multiple Organ Failure; Oxidative Stress; Rats; Rats, Wistar

2021
A 36-Year-Old Woman Presenting With Left Upper Quadrant Discomfort, Encephalopathy, and Respiratory Failure.
    Chest, 2020, Volume: 157, Issue:4

    A 36-year-old woman with a history of hypertension and alcoholism reported 2 days of left upper quadrant pain and jaundice. Within hours of admission, she became somnolent and hypoxic. The patient was then intubated. She had no history of drug abuse, cigarette smoking, liver disease, autoimmune disease, or pancreatitis. She had no home medications.

    Topics: Abdominal Pain; Adult; Anti-Bacterial Agents; Antibodies, Anticardiolipin; Anticoagulants; Antiphospholipid Syndrome; Brain Diseases; Cefepime; Diagnosis, Differential; Female; Heparin; Humans; Magnetic Resonance Imaging; Multiple Organ Failure; Respiratory Insufficiency; Thrombosis; Tomography, X-Ray Computed; Treatment Outcome; Vancomycin

2020